Identification of a Novel Integrin α6β1 Binding Site in the Angiogenic Inducer CCN1 (CYR61)
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The angiogenic inducer CCN1 (cysteine-rich 61, CYR61), a secreted matricellular protein of the CCN family, is a ligand of multiple integrins, including alpha 6 beta 1. Previous studies have shown that CCN1 interaction with integrin alpha 6 beta 1 mediates adhesion of fibroblasts, endothelial cells, and smooth muscle cells, as well as migration of smooth muscle cells. Recently, we have reported that CCN1-induced tubule formation of unactivated endothelial cells is also mediated through integrin alpha 6 beta 1. In this study, we demonstrate that human skin fibroblasts adhere specifically to the T1 sequence (GQKCIVQTTSWSQCSKS) within domain III of CCN1, and this process is blocked by anti-alpha 6 and anti-beta 1 monoclonal antibodies. Alanine substitution mutagenesis of the T1 sequence further defines the sequence TTSWSQCSKS as the critical determinant for mediating alpha 6 beta 1-dependent adhesion. Soluble T1 peptide specifically inhibits fibroblast adhesion to CCN1 in a dose-dependent manner. Furthermore, T1 also inhibits cell adhesion to other alpha 6 beta 1 ligands, including CCN2 (CTGF), CCN3 (NOV), and laminin, but not to ligands of other integrins. In addition, T1 specifically inhibits alpha 6 beta 1-dependent tubule formation of unactivated endothelial cells in a CCN1-containing collagen gel matrix. To confirm that T1 binds integrin alpha 6 beta 1 directly, we perform affinity chromatography and show that integrin alpha 6 beta 1 is isolated from an octylglucoside extract of fibroblasts on T1-coupled Affi-gel. Taken together, these findings define the T1 sequence in CCN1 as a novel binding motif for integrin alpha 6 beta 1, providing the basis for the development of peptide mimetics to examine the functional role of alpha 6 beta 1 in angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This inhibitory effect was observed with both CCN1 and D125A‐CCN1 mutant protein unable to bind αvβ3/αvβ5 [ 23 ] but not with DM‐CCN1 mutant protein[ 27 ] unable to bind integrin α6β1 (Figure 2C).”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“CCN1 does not contain the canonical RGD sequence that can bind a number of integrins [54]. Instead, specific non-canonical binding sites of CCN1 for several integrins have been identified (Fig. 1) [63–66].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Matricellular proteins: extracellular modulators of cell function
Bornstein, P., & Sage, E. H. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00361-7 · Cited by 965
Isberg, R. R., & Leong, J. M. (1990) · Cell · doi:10.1016/0092-8674(90)90099-z · Cited by 798
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
The CCN Family of Angiogenic Regulators: The Integrin Connection
Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 648
Self-citationTolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., & Lau, L. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6355 · Cited by 495
Self-citationMouse egg integrin α6β1functions as a sperm receptor
Almeida, E. A. C., Huovila, A.-P. J., Sutherland, A. E., Stephens, L. E., Calarco, P. G., Shaw§, L. M., Mercurio, A. M., Sonnenberg, A., Primakoff, P., Myles, D. G., et al. (1995) · Cell · doi:10.1016/s0092-8674(05)80014-5 · Cited by 470
Babic, A. M., Chen, C.-C., & Lau, L. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2958 · Cited by 450
Self-citationCYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity
Mo, F.-E., Muntean, A. G., Chen, C.-C., Stolz, D. B., Watkins, S. C., & Lau, L. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8709-8720.2002 · Cited by 416
Self-citationShimo, T., Nakanishi, T., Nishida, T., Asano, M., Kanyama, M., Kuboki, T., Tamatani, T., Tezuka, K., Takemura, M., Matsumura, T., et al. (1999) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022414 · Cited by 405
Sonnenberg, A., Linders, C. J., Modderman, P. W., Damsky, C. H., Aumailley, M., & Timpl, R. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.6.2145 · Cited by 404
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues
Perbal, B. (2001) · Molecular Pathology · doi:10.1136/mp.54.2.57 · Cited by 348
Kireeva, M. L., Mo, F.-E., Yang, G. P., & Lau, L. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1326 · Cited by 341
Self-citationXie, D., Nakachi, K., Wang, H., Elashoff, R. M., & Koeffler, H. P. (2001) · PubMed · Cited by 332
Chen, C.-C., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008087200 · Cited by 305
Self-citationThe Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts
Chen, C.-C., Mo, F.-E., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107666200 · Cited by 300
Self-citationNomizu, M., Kim, W. H., Yamamura, K., Utani, A., Song, S.-Y., Otaka, A., Roller, P. P., Kleinman, H. K., & Yamada, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20583 · Cited by 253
Proposal for a unified CCN nomenclature: Table 1
Brigstock, D. R., Goldschmeding, R., Katsube, K.-I., Lam, S. C.-T., Lau, L. F., Lyons, K., Naus, C., Perbal, B., Riser, B., Takigawa, M., et al. (2003) · Molecular Pathology · doi:10.1136/mp.56.2.127 · Cited by 250
Self-citationLeu, S.-J., Lam, S. C.-T., & Lau, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209288200 · Cited by 247
Self-citationSchober, J. M., Chen, N., Grzeszkiewicz, T. M., Jovanovic, I., Emeson, E. E., Ugarova, T. P., Ye, R. D., Lau, L. F., & Lam, S. C.-T. (2002) · Blood · doi:10.1182/blood.v99.12.4457 · Cited by 242
Self-citationMyles, D. G., Kimmel, L. H., Blobel, C. P., White, J. M., & Primakoff, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4195 · Cited by 235
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family
Lin, C. G., Leu, S.-J., Chen, N., Tebeau, C. M., Lin, S.-X., Yeung, C.-Y., & Lau, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302028200 · Cited by 214
Self-citationJedsadayanmata, A., Chen, C.-C., Kireeva, M. L., Lau, L. F., & Lam, S. C.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24321 · Cited by 204
Self-citationKireeva, M. L., Lam, S. C.-T., & Lau, L. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3090 · Cited by 203
Self-citationYang, G. P., & Lau, L. F. (1991) · PubMed · Cited by 200
Self-citationChen, N., Chen, C.-C., & Lau, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003040200 · Cited by 195
Self-citationCyr61 promotes breast tumorigenesis and cancer progression
Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189
Grzeszkiewicz, T. M., Kirschling, D. J., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100978200 · Cited by 162
Self-citationKramer, R. H., Cheng, Y. F., & Clyman, R. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1233 · Cited by 153
Xie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009755200 · Cited by 146
Tsai, M.-S., Hornby, A. E., Lakins, J. N., & Lupu, R. (2000) · PubMed · Cited by 132
A Mechanism for Regulation of Melanoma Invasion
Nakahara, H., Nomizu, M., Akiyama, S. K., Yamada, Y., Yeh, Y., & Chen, W.-T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27221 · Cited by 120
Hilfiker, A., Hilfiker-Kleiner, D., Fuchs, M., Kaminski, K., Lichtenberg, A., Rothkötter, H.-J., Schieffer, B., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000021426.87274.62 · Cited by 114
CD36 associates with CD9 and integrins on human blood platelets
Miao, W.-M., Vasile, E., Lane, W. S., & Lawler, J. (2001) · Blood · doi:10.1182/blood.v97.6.1689 · Cited by 107
Sampath, D., Winneker, R. C., & Zhang, Z. (2001) · Endocrinology · doi:10.1210/endo.142.6.8186 · Cited by 98
Cheng, Y., & Kramer, R. H. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390209 · Cited by 94
The Integrins α3β1 and α6β1 Physically and Functionally Associate with CD36 in Human Melanoma Cells
Thorne, R. F., Marshall, J. F., Shafren, D. R., Gibson, P. G., Hart, I. R., & Burns, G. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003969200 · Cited by 90
Promoter function and structure of the growth factorinducible immediate early gene cyr 61
Latinkic, B. V., Brien, T. P. O., & Lau, L. F. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.12.3261 · Cited by 87
Self-citationThe use of a combinatorial library method to isolate human tumor cell adhesion peptides
Pennington, M. E., Lam, K. S., & Cress, A. E. (1996) · Molecular Diversity · doi:10.1007/bf01718696 · Cited by 70
Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock, I. B., Pennington, M. E., Sroka, T. C., Lam, K. S., Bowden, G. T., Bair, E. L., & Cress, A. E. (2001) · PubMed · Cited by 60
Stimulation of Angiogenesis by Cyr61 Gene: A New Therapeutic Candidate
Fataccioli, V., Abergel, V., Wingertsmann, L., Neuville, P., Spitz, E., Adnot, S., Calenda, V., & Teiger, E. (2002) · Human Gene Therapy · doi:10.1089/10430340260185094 · Cited by 58
Novel Peptide Ligands for Integrin 6 1 Selected from a Phage Display Library
Murayama, O., Nishida, H., & Sekiguchi, K. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021431 · Cited by 43
Acuña-Cueva, E. R., Hueso‐Ureña, F., Jiménez‐Pulido, S. B., & Moreno‐Carretero, M. N. (2000) · Journal of Molecular Modeling · doi:10.1007/s0089400060433 · Cited by 27
Wu, K. J., Yee, A., Zhu, N. L., Gordon, E. M., & Hall, F. L. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.6.4.433 · Cited by 24
Grzeszkiewicz, T. M. (2002) · Endocrinology · doi:10.1210/en.143.4.1441 · Cited by 23
Self-citation
Research works printed but not linked: 4
- Xie, 2001, Cancer Res., 61, 8917
- Tsai, 2000, Cancer Res., 60, 5603
- Yang, 1991, Cell Growth Differ., 2, 351
- DeRoock, 2001, Cancer Res., 61, 3308
Cited by
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
“Unlike α6β4, which shows a preference for laminin 5, integrin α6β1 binds most laminin isoforms as well as other ECM proteins including CYR61 , thrombospondin 1 and thrombospondin 2 (Ref”
BackgroundJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998
“Furthermore, the addition of a peptide that competitively binds α 6 β 1 integrin specifically (T1; ref”
BackgroundSelf-citationCCN proteins: multifunctional signalling regulators
Perbal, B. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15172-0 · Cited by 704
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
Leask, A., & Abraham, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 655
“CCN proteins promote adhesion through both integrins and HSPGs, although the identity of the integrins and HSPGs differ, depending on the system and cell type examined (Chen et al., 2000; Ellis et al., 2003; Leu et al., 2003; Gao and Brigstock, 2004; Chen, Y. et al., 2004).”
BackgroundTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
Self-citation
Metadata
- Authors
- Leu, S.-J., Liu, Y., Chen, N., Chen, C.-C., Lam, S. C.-T., & Lau, L. F.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Lau, Lester F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 278
- Issue
- 36
- Pages
- 33801-33808
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2092758437
- Cited by
- 131
- References
- 49
- Citations by year
- 2025: 5 · 2024: 1 · 2023: 1 · 2022: 9 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 7 · 2012: 5
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6236 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca080080-05)
- National Heart, Lung, and Blood Institute (HL41793)
- National Cancer Institute (CA-80080, R01CA046565, CA-46565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- CYR61, alpha6beta1 integrin, integrin binding site, matricellular proteins, CCN family, cell adhesion, fibroblasts, angiogenesis, peptidomimetics, laminin, connective tissue growth factor, CCN3, collagen gel matrix
- MeSH terms
- Alanine, Amino Acid Sequence, Binding Sites, Cell Adhesion, Cell Line, Cell Membrane, Cell Movement, Cells, Cultured, Chromatography, Dose-Response Relationship, Drug, Endothelium, Vascular, Fibroblasts, Glutathione Transferase, Humans, Models, Biological, Molecular Sequence Data, Peptides, Precipitin Tests, Protein Binding, Recombinant Fusion Proteins, Sepharose, Umbilical Veins, Integrins, Mutagenesis, Site-Directed, Protein Structure, Tertiary, Immediate-Early Proteins, Amino Acid Motifs, Intercellular Signaling Peptides and Proteins, Integrin alpha6beta1, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.